Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, o...

por Marukutira, Tafireyi, Huprikar, Shirish, Azie, Nkechi, Quan, Shun-Ping, Meier-Kriesche, Herwig-Ulf, Horn, David L
Publicado 2014

Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups

por Campbell, Rebecca S, Chaudhari, Paresh, Hays, Harlen D, Taylor, Robert J, Nathanson, Brian H, Bozzette, Samuel A, Horn, David L
Publicado 2013

Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008

por Pfaller, Michael A., Andes, David R., Diekema, Daniel J., Horn, David L., Reboli, Annette C., Rotstein, Coleman, Franks, Billy, Azie, Nkechi E.
Publicado 2014

Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy

por Zorzopulos, Jorge, Opal, Steven M, Hernando-Insúa, Andrés, Rodriguez, Juan M, Elías, Fernanda, Fló, Juan, López, Ricardo A, Chasseing, Norma A, Lux-Lantos, Victoria A, Coronel, Maria F, Franco, Raul, Montaner, Alejandro D, Horn, David L
Publicado 2017